Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HAUS augmin like complex subunit 6 pseudogene 3 (HAUS6P3) is classified as a *processed pseudogene* due to its sequence homology with the functional HAUS6 gene, but it contains defects (such as frameshifts, stop codons, or loss of regulatory elements) that prevent transcription or translation into a functional protein[2][3]. As a pseudogene, it cannot serve as a therapeutic target like receptors, enzymes, or transporters; in nearly all cases, pseudogenes lack canonical biological activity, are not disease drivers, and are not relevant for drug targeting. There are rare exceptions where some pseudogenes play regulatory roles, but there is no evidence HAUS6P3 is among them[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HAUS augmin like complex subunit 6 pseudogene 3 (HAUS6P3).